Astrazeneca's Immuno-oncology Candidate Shows Promise
What is Immuno-oncology: Immuno-oncology is a therapeutic approach that stimulates the body’s immune system to attack tumours. Oncology is undoubtedly one of the most active R&D areas in pharma. The immunotherapeutic field is in its infancy and contains a variety of areas including immune checkpoint inhibitors, cancer vaccines and monoclonal and conjugated antibodies.AstraZeneca and its global biologics research and development arm, MedImmune recently announced updated efficacy and saf...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.